At the end of March, NGen announced that it would allocate $50 million in Supercluster funding to launch production of innovative manufacturing solutions that could contribute in the fight against COVID-19.
NGen’s Rapid Response Funding Program was aimed at delivering critical products to front line health care workers within three months, by the end of June. NGen also announced in May a challenge to develop and manufacture disinfecting robots that would enable facilities to operate safely and help businesses get back to work.
To date, NGen has received over 900 expressions of interest from across the country. Working with the Government of Canada to identify critical health care priorities and supply shortages, NGen has invested in 19 projects involving the development and manufacturing of PPE, test kits, ventilators, as well as disinfecting agents and equipment. We have also connected many companies to other sources of government funding, most notably federal procurement challenges for ventilators, test kits, and various types of PPE. We have been truly inspired by the innovation and mobilization we have seen across Canadian industry in response to the pandemic.
As of June 3rd, NGen will no longer be accepting applications to its COVID-19 Rapid Response Funding Program.
However, NGen will continue to launch strategic challenges that will be intended to help both in the fight against COVID-19 and in building advanced manufacturing capabilities in Canada. Applications for these funding challenges can be made when these programs are announced.
Although NGen’s intake process has closed for our Rapid Response Funding Program, your project idea may be eligible for other sources of funding. You can find more information and check out some key funding opportunities by accessing the COVID-19 Resource Bank above.
If you would like NGen to seek other funding opportunities for your project idea, please indicate your consent for us to do so and the information you are willing to share here.